Oxford Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-2,982
| Closed | -$237K | – | 1521 |
|
|
2019
Q4 | $237K | Buy |
+2,982
| New | +$237K | 0.01% | 1503 |
|
|
2018
Q4 | – | Sell |
-46,966
| Closed | -$1.79M | – | 2202 |
|
|
2018
Q3 | $1.79M | Buy |
46,966
+26,996
| +135% | +$1.03M | 0.04% | 725 |
|
|
2018
Q2 | $923K | Buy |
19,970
+5,629
| +39% | +$260K | 0.02% | 1078 |
|
|
2018
Q1 | $693K | Sell |
14,341
-13,783
| -49% | -$666K | 0.01% | 1105 |
|
|
2017
Q4 | $1.11M | Sell |
28,124
-1,565
| -5% | -$61.6K | 0.02% | 886 |
|
|
2017
Q3 | $900K | Sell |
29,689
-38,397
| -56% | -$1.16M | 0.02% | 982 |
|
|
2017
Q2 | $1.86M | Sell |
68,086
-50,409
| -43% | -$1.38M | 0.04% | 640 |
|
|
2017
Q1 | $4.37M | Sell |
118,495
-22,350
| -16% | -$824K | 0.11% | 180 |
|
|
2016
Q4 | $2.04M | Buy |
140,845
+102,200
| +264% | +$1.48M | 0.07% | 321 |
|
|
2016
Q3 | $891K | Buy |
+38,645
| New | +$891K | 0.03% | 539 |
|